KRC-00715
Product Specifications
Target
C-Met/HGFR
Related Pathways
Tyrosine Kinase/Adaptors
Bioactivity
KRC-00715 is an orally effective inhibitor of c-Met, exhibiting high selectivity with an IC50 of 9.0 nM. This compound specifically inhibits the growth of gastric cancer cell lines with high c-Met expression by inducing G1/S phase block, and reduces the activity of downstream signals, including Akt, Erk, and c-Met itself. In the gastric cancer cell line Hs746T, KRC-00715 demonstrates cytotoxicity with an IC50 of 39 nM and selectively inhibits the proliferation of cell lines that overexpress c-Met. Additionally, KRC-00715 decreases tumor size in Hs746T xenograft mouse models.
Smiles
FC(F)(F)C=1C=C(C=CC1OCCN2CCOCC2)C3=NC4=C(N=NN4CC5OC6=CC=CN=C6NC5)N=C3
Molecular Formula
C25H25F3N8O3
Molecular Weight
542.51
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/240554467198501013/T200380
CAS Number
2079853-72-6
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1331808-01 0.02 mg (E-Coli)
Recombinant Arabidopsis thaliana Protease Do-like 8, chloroplastic (DEGP8)
Ask
View Details 
MBS1331808-02 0.02 mg (Yeast)
Recombinant Arabidopsis thaliana Protease Do-like 8, chloroplastic (DEGP8)
Ask
View Details MBS1331808-03 0.1 mg (E-Coli)
Recombinant Arabidopsis thaliana Protease Do-like 8, chloroplastic (DEGP8)
Ask
View Details